Zuoyi Jiao

16PUBLICATIONS
54CO-AUTHORS
Molecular targetsCancer diagnosisCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 23, 2026
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

|Jul 02, 2026
USP20 promotes CD8+ T cell exhaustion and impairs KRASG12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer.

|Jun 08, 2026
Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response.

|Feb 15, 2026
UBE2T-Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation-Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer.

Yong Ma, Wenbo Liu, Mingdou Li

|Nov 06, 2025
USP20-Driven Cholesterol Metabolism Links Inflammatory Signaling to Malignancy and Stromal Coevolution in Pancreatic Cancer.

Xiangyan Jiang, Bin Zhao, Tao Wang

|Aug 27, 2025
Targeting the ANXA8-SP1-PPA1 Axis to Modulate TCA Cycle and Matrix Deposition in Diffuse-Type Gastric Cancer.

Yuxia Wu, Xiangyan Jiang, Huiguo Qing

Pageof 3

Frequent Collaborators

8 joint publications

Long Qin

6 joint publications

Wengui Shi

5 joint publications

Xiangyan Jiang

4 joint publications

Zeyuan Yu